Patents
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
06/2005
06/02/2005WO2005049589A2 Heterocyclic compounds for the treatment of hyperlipidemia, diabetes, obesity and similar diseases
06/02/2005WO2005049581A1 Pyridazin-3 (2h) -one derivatives and their use as pde4 inhibitors
06/02/2005WO2005049579A2 Immobilized n-substituted tricyclic 3-aminopyrazoles for the identification of biomolecular targets
06/02/2005WO2005049569A1 2-ethyl-4,6-dimethyl-phenyl-substituted spirocyclic tetramic acid derivatives
06/02/2005WO2005049033A1 Pyrazole derivatives as inhibitors of receptor tyrosyne kinases
06/02/2005WO2005048953A2 Amide derivatives as kinase modulators
06/02/2005WO2005048948A2 Urea derivatives as kinase modulators
06/02/2005WO2005048922A2 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors
06/02/2005WO2005048710A1 2-ethyl-4,6-dimethyl-phenyl-substituted tetramic acid derivatives as pest control agents and/or herbicides
06/02/2005US20050119495 For use as catalysts in asymmetric reactions, such as, hydrogenation, hydride transfer, allylic alkylation, hydrosilylation, hydroboration, hydrovinylation, hydroformylation, olefin metathesis, hydrocarboxylation
06/02/2005US20050119486 Diamine derivatives
06/02/2005US20050119332 Substituted thiophene compounds as modulators of protein tyrosine phosphatases (PTPases)
06/02/2005US20050119329 Tetronic and tetramic acids
06/02/2005US20050119311 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
06/02/2005US20050119228 Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof
06/02/2005DE10335545A1 New bicyclic nitrogen-containing heteroaryl-substituted amides, are inhibitors of Factor Xa and/or related serine proteases, useful as antithrombotic agents, e.g. for treating or preventing deep leg vein thrombosis
06/02/2005CA2546817A1 2-ethyl-4,6-dimethyl-phenyl-substituted tetramic acid derivatives as pest control agents and/or herbicides
06/02/2005CA2546815A1 2-ethyl-4,6-dimethyl-phenyl-substituted spirocyclic tetramic acid derivatives
06/02/2005CA2545725A1 Bicyclic pyrimidin-4-(3h)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (vr1)
06/02/2005CA2545711A1 Urea derivatives as kinase modulators
06/02/2005CA2545193A1 Pyridazin-3 (2h) -one derivatives and their use as pde4 inhibitors
06/01/2005EP1535909A2 Cyclic amine derivatives and their use as drugs
06/01/2005EP1534716A1 Heterobicyclic pyrazole derivatives as kinase inhibitors
06/01/2005EP1534702A1 Two-photon absorption heteroaromatic chromophores and compositions thereof
06/01/2005EP1534273A2 Modulators of the glucocorticoid receptor and method
05/2005
05/31/2005US6900217 Substituted 6,5-hetero-bicyclic derivatives
05/31/2005US6899990 Epoxy compound having alicyclic structure, polymer, resist composition and patterning process
05/31/2005CA2195776C Novel process for the preparation of diisopinocampheylchloroborane
05/26/2005WO2005047293A1 Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
05/26/2005WO2005047292A1 Use of thienopyrimidines
05/26/2005WO2005047266A1 Aryl imidazoles and their use as anti-cancer agents
05/26/2005WO2005047252A1 Sulfonyltetrahydro-3h-benzo(e)indole-8-amine compounds as 5-hydroxytryptamine-6 ligands
05/26/2005WO2005047247A1 Novel1,3-disubstituted azetidine derivatives for use as 5ht2a receptor ligands
05/26/2005WO2005047246A1 Novel 1, 3-disubstituted azetidine deivatives for use as 5ht2a receptor ligands
05/26/2005WO2005046588A2 Compounds, compositions, and methods
05/26/2005WO2004041830A3 An improved process for the preparation of biotin
05/26/2005US20050113406 Blood platelet aggregation inhibiting and antithrombotic effect; uniform crystal form; reproducable industrial scale manufacture
05/26/2005US20050112693 Screening, biosynthesis of peptides
05/26/2005CA2545373A1 Novel 1,3-disubstituted azetidine derivatives for use as 5ht2a receptor ligands
05/26/2005CA2544550A1 Use of thienopyrimidines
05/26/2005CA2543627A1 Sulfonyltetrahydro-3h-benzo(e)indole-8-amine compounds as 5-hydroxytryptamine-6 ligands
05/25/2005EP1533318A1 Prodrugs of thrombin inhibitors
05/25/2005EP1533314A1 Process for producing cyclic thioether and synthetic intermediate thereof
05/25/2005EP1532154A1 Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone
05/25/2005EP1286673B1 Ligands of integrin receptors
05/25/2005CN1620458A 噻吩并嘧啶 Thienopyrimidine
05/25/2005CN1620439A Pancreatic lipase inhibitor compounds, their synthesis and use
05/25/2005CN1620434A Pyrrolidine-2-ones as factor Xa inhibitors
05/25/2005CN1620293A Polymorphs of clopidogrel hydrogensulfate
05/25/2005CN1203066C (Methylsulfonyl) phenyl-2-(5H)-furanones as cos-2 inhibitors
05/24/2005US6897220 Antiproliferative agents
05/24/2005US6897211 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
05/24/2005CA2195615C A process for the manufacture of imidazodiazepine derivatives
05/19/2005WO2005044816A1 Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof
05/19/2005WO2005044008A2 2 -aminothiophene compounds as fungicides
05/19/2005WO2004041780A3 N-(indole-2-carbonyl) amides as anti-diabetic agents
05/19/2005WO2004037811A8 Selected cgrp antagonists, method for production and use thereof as medicament
05/19/2005US20050107458 used as diagnostic kits, bioassay and/or drugs for preventing cancers, Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, stroke, ischaemia, Huntington's disease, epilepsy, multiple sclerosis, neuropathy, or injuries of the brain or spinal chord, or as tyrosine kinase inhibitors
05/19/2005US20050107389 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands
05/19/2005US20050107379 antithrombolytic agents such as (E)-2-(5-Chlorothien-2-yl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide, used for therapy of cardiovascular disorders
05/18/2005EP1530573A1 Condensed heterocyclic pyrazole derivatives as kinase inhibitors
05/18/2005EP1176139B1 Medicinal compositions with 2.2.1] and 3.1.1] bicycloskeleton antagonistic to both of pgd 2?/txa 2? receptors
05/18/2005EP1007050B1 Olanzapine for treating substance abuse
05/18/2005CN1616464A Method for preparing diester dibenzyl biotin
05/18/2005CN1616463A Process for preparing dibenzyl biotin
05/18/2005CN1616454A Preparation of thiophene monomer and its polymerizing method
05/18/2005CN1616451A Process for the purification of thiophenes
05/18/2005CN1616446A Polysubstituted benzo hetero aromatic ring and method for one step synthesizing polysubstituted benzo hetero aromatic ring
05/17/2005US6894186 Carbocyclic oxy esters, such as methyl 2-benzenesulphonyloxy-2(2-chlorophenyl) acetate, used as chemical intermediates for anticoagulants such as clopidrogel
05/17/2005US6894055 Thieno-2′,3′ -5,6pyrimido[3,4-A]-1,2,4-triazole derivatives as modulators of phoshoinositide 3-kinase
05/17/2005US6893650 Fungicides; locus infestation; such as N,N-dimethyl-N'-(4-(3-trifluoromethylbenzylthio)-2,5-xylyl)formamidine
05/12/2005WO2005042666A1 New compound capable of being used in organic layer of organic light emitting device
05/12/2005WO2005042541A1 3-(4-aminophenyl) thienopyrimid-4-one derivatives as mch r1 antagonists for the treatment of obesity, diabetes, depression and anxiety
05/12/2005WO2005042540A1 Thieno-pyridinone derivatives as kinase inhibitors
05/12/2005WO2005042537A1 Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors
05/12/2005WO2005042513A1 Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase
05/12/2005WO2005042504A1 Fluorinated resorufin compounds and their application in detecting hydrogen peroxide
05/12/2005WO2005041957A1 Oxindole derivatives and their use as phosphodiesterase type 2 inhibitors
05/12/2005WO2004089312A3 New piperidinylamino-thieno[2,3-d] pyrimidine compounds
05/12/2005WO2004064778A3 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
05/12/2005US20050101601 Substituted tricyclic heterocycles and their uses
05/12/2005US20050101596 Such as N,N-dimethyl-3-(phenylsulfonyl)-6,7,8,9-tetrahydro-3H-benzo[e]indol-8-amine; for treatment of central nervous system disorders related to or affected by serotonin receptor antagonists such as neurodegenerative disorders, attention deficit disorder, obsessive compulsive disorder, and drug abuse
05/12/2005US20050101586 Novel 5-HT2A receptor ligands
05/12/2005CA2543122A1 3-(4-aminophenyl) thienopyrimid-4-one derivatives as mch r1 antagonists for the treatment of obesity, diabetes, depression and anxiety
05/12/2005CA2540881A1 Thieno-pyridinone derivatives as kinase inhibitors
05/12/2005CA2540843A1 Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase
05/11/2005EP0854915B1 Cd23 cleavage enzyme preparation
05/11/2005CN1615311A 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide
05/10/2005US6890923 Thieno(2,3-d)pyrimidine-2,4-diones and their synthesis; for immunosuppression; treating airway diseases such as asthma
05/10/2005CA2191815C Heterocyclic compounds having tachykinin receptor antagonist activity, their preparation and their use
05/06/2005WO2005040355A2 Tao kinase modulators and methods of use
05/06/2005CA2542064A1 Tao kinase modulators and methods of use
05/05/2005US20050096469 Mono-ester and asymmetrically substatuted di-ester pro-drugs of dopamide d1 receptor agonists
05/05/2005US20050096315 Fluorinated resorufin compounds and their application
05/05/2005US20050096309 For use as anticoagulant agents for therapy of thromboembolic disorders
05/04/2005EP1527076A1 Dihydro-dibenzo (b,e) oxepine based selective estrogen receptor modulators, compositions and methods
05/04/2005EP1527070A1 Azole methylidene cyanide derivatives and their use as protein kinase modulators
05/04/2005EP1526895A2 Methods for treating carbonic anhydrase mediated disorders
05/04/2005EP1526869A1 Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia
05/04/2005EP1317448B1 Pyrazole compounds useful as protein kinase inhibitors